At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Non-Inferiority Randomized Trial Comparing the Impact of Thoracic Epidural Analgesia Versus Surgical Site Infiltration With Liposomal Bupivicaine on the Postoperative Recovery of Patients Following Open Gynecologic Surgery
In Brief
A Phase 3 clinical trial evaluating Liposomal bupivacaine and Thoracic epidural analgesia (bupivacaine) for Surgery and Analgesia. Completed, enrolled 106 participants across 1 site.
Detailed Summary
The goal of this study is to test the hypothesis that surgical site infiltration with liposomal bupivacaine (LB) is non-inferior to and more cost effective than thoracic epidural analgesia (TEA) for patients undergoing open gynecologic surgery on an established enhanced recovery program (ERP) using a non-inferiority randomized trial design. The impact of TEA and surgical site infiltration with LB on neuroendocrine and inflammatory mediators of surgical stress response (SSR) will also be investigated as a translational endpoint.
Study Details
Timeline
Interventions
Surgical site infiltration with 20 mL liposomal bupivacaine prior to laparotomy closure.
Perioperative bupivacaine based thoracic epidural placed preoperatively.